PortfoliosLab logoPortfoliosLab logo
Clover Health Investments, Corp. (CLOV)
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN
US18914F1030
IPO Date
Jan 2, 2001

Highlights

Market Cap
$910.34M
Enterprise Value
$832.04M
EPS (TTM)
-$0.17
Total Revenue (TTM)
$1.92B
Gross Profit (TTM)
$1.99B
EBITDA (TTM)
-$83.86M
Year Range
$1.70 - $3.92
Target Price
$3.00
ROA (TTM)
-15.81%
ROE (TTM)
-27.71%

Share Price Chart


Loading graphics...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Clover Health Investments, Corp., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


Loading graphics...

S&P 500 Index

Returns By Period

Clover Health Investments, Corp. (CLOV) has returned -25.11% so far this year and -50.97% over the past 12 months.


Clover Health Investments, Corp.

1D
2.33%
1M
-15.79%
YTD
-25.11%
6M
-42.48%
1Y
-50.97%
3Y*
27.70%
5Y*
-24.93%
10Y*

Benchmark (S&P 500 Index)

1D
2.91%
1M
-5.09%
YTD
-4.63%
6M
-2.39%
1Y
16.33%
3Y*
16.69%
5Y*
10.18%
10Y*
12.16%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Monthly Returns

Based on dividend-adjusted daily data since Jun 12, 2020, CLOV's average daily return is +0.02%, while the average monthly return is +0.46%. At this rate, your investment would double in approximately 12.6 years.

Historically, 40% of months were positive and 60% were negative. The best month was May 2024 with a return of +74.6%, while the worst month was Jul 2021 at -39.4%. The longest winning streak lasted 6 consecutive months, and the longest losing streak was 5 months.

On a daily basis, CLOV closed higher 45% of trading days. The best single day was Jun 8, 2021 with a return of +85.8%, while the worst single day was Jun 9, 2021 at -23.6%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2026-4.68%-6.70%-15.79%-25.11%
202539.37%-9.57%-9.57%-5.29%-7.65%-11.15%3.58%-9.34%16.79%15.36%-29.46%-5.62%-25.40%
20240.64%-9.84%-8.09%-20.65%74.60%11.82%55.28%37.70%7.22%46.10%-15.53%-9.48%230.85%
202343.09%-0.75%-35.98%-12.60%14.66%5.93%39.34%4.80%-17.56%-11.73%-3.39%3.38%2.43%
2022-30.65%5.43%30.51%-24.23%-0.74%-19.85%30.84%-6.79%-34.87%-7.06%-17.09%-29.05%-75.01%
2021-16.82%-32.62%-19.57%30.29%-22.44%74.35%-39.41%6.32%-13.87%1.49%-33.87%-25.00%-77.82%

Benchmark Metrics

Clover Health Investments, Corp. has an annualized alpha of -16.38%, beta of 1.48, and R² of 0.08 versus S&P 500 Index. Calculated based on daily prices since June 15, 2020.

  • This stock participated in 216.80% of S&P 500 Index downside but only 83.74% of its upside — more exposed to losses than it benefited from rallies.
  • R² of 0.08 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
-16.38%
Beta
1.48
0.08
Upside Capture
83.74%
Downside Capture
216.80%

Return for Risk

Risk / Return Rank

CLOV ranks 8 for risk / return — in the bottom 8% of stocks on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.


CLOV Risk / Return Rank: 88
Overall Rank
CLOV Sharpe Ratio Rank: 99
Sharpe Ratio Rank
CLOV Sortino Ratio Rank: 1010
Sortino Ratio Rank
CLOV Omega Ratio Rank: 1111
Omega Ratio Rank
CLOV Calmar Ratio Rank: 66
Calmar Ratio Rank
CLOV Martin Ratio Rank: 55
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for Clover Health Investments, Corp. (CLOV) and compare them to a chosen benchmark (S&P 500 Index).


CLOVBenchmarkDifference

Sharpe ratio

Return per unit of total volatility

-0.78

0.90

-1.67

Sortino ratio

Return per unit of downside risk

-1.06

1.39

-2.44

Omega ratio

Gain probability vs. loss probability

0.87

1.21

-0.34

Calmar ratio

Return relative to maximum drawdown

-0.93

1.40

-2.33

Martin ratio

Return relative to average drawdown

-1.69

6.61

-8.30

Explore CLOV risk-adjusted metrics in detail

Dive deeper into individual metrics with historical trends, benchmark comparisons, and performance across different time periods.

Dividends

Dividend History


Clover Health Investments, Corp. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading graphics...

Worst Drawdowns

The table below displays the maximum drawdowns of the Clover Health Investments, Corp.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Clover Health Investments, Corp. was 97.19%, occurring on Apr 17, 2024. The portfolio has not yet recovered.

The current Clover Health Investments, Corp. drawdown is 92.05%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-97.19%Jun 9, 2021719Apr 17, 2024
-60.05%Dec 29, 202096May 17, 202115Jun 8, 2021111
-24.35%Sep 30, 202032Nov 12, 202026Dec 21, 202058
-7.48%Jul 13, 202029Aug 20, 202015Sep 11, 202044
-7.25%Sep 21, 20204Sep 24, 20203Sep 29, 20207

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading graphics...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Clover Health Investments, Corp. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Clover Health Investments, Corp. is priced in the market compared to other companies in the Healthcare Plans industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for CLOV relative to other companies in the Healthcare Plans industry. Currently, CLOV has a P/S ratio of 0.5. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for CLOV in comparison with other companies in the Healthcare Plans industry. Currently, CLOV has a P/B value of 2.9. This P/B ratio is higher than most companies in the industry. It may suggest the stock is overvalued or that investors expect the company to generate high returns on its assets.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items